Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis-Reference-Cited by-同舟云学术

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

Published:2015-07-24 Issue:8 Volume:85 Page:722-729
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Novotna Martina,Paz Soldán M. Mateo,Abou Zeid Nuhad,Kale Nilufer,Tutuncu Melih,Crusan Daniel J.,Atkinson Elizabeth J.,Siva Aksel,Keegan B. Mark,Pirko Istvan,Pittock Sean J.,Lucchinetti Claudia F.,Noseworthy John H.,Weinshenker Brian G.,Rodriguez Moses,Kantarci Orhun H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference40 articles.

1. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study

2. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants

3. Demyelinating events in early multiple sclerosis have inherent severity and recovery

4. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

5. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-up;Multiple Sclerosis and Related Disorders;2024-09

2. Real-world effectiveness of disease-modifying therapies in older adults with multiple sclerosis;Journal of Medicine, Surgery, and Public Health;2024-08

3. Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis;Journal of Multiple Sclerosis and Neuroimmunology;2024-06-30

4. Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses;European Journal of Neurology;2024-05-03

5. Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study;Neurologia i Neurochirurgia Polska;2024-04-30